RVL Pharmaceuticals
Jennifer (Alvarez) Hanlon currently serves as the Head of Digital Marketing and Consumer Technology at RVL Pharmaceuticals since January 2024. Prior to this role, Jennifer held multiple senior positions at 2U from August 2008 to October 2023, including SVP of Customer and Partner Marketing, SVP of Marketing Strategy, and SVP of Marketing Operations. Jennifer's earlier experience includes serving as Senior Marketing Manager at Smarterville Inc., where significant contributions were made to shift the company's focus towards consumer products. Additional experience includes managing large-scale advertising accounts at YPM and coordinating events for the TGR Foundation. Jennifer is pursuing a Certificate in Data Analysis for Management from The London School of Economics and holds a Bachelor of Science in Sociology from UC Irvine.
This person is not in any offices
RVL Pharmaceuticals
RVL Pharmaceuticals plc is a specialty pharmaceutical company focused on the commercialization and development of products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas. The Company is currently commercializing UPNEEQ® (oxymetazoline hydrocholoride ophthalmic solution), 0.1%, for the treatment of acquired blepharoptosis, or low-lying eyelid, in adults. UPNEEQ is the first non-surgical treatment option approved by the FDA for acquired blepharoptosis.